Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:52 AM
Ignite Modification Date:
2025-12-24 @ 11:52 AM
NCT ID:
NCT04509661
Eligibility Criteria:
Inclusion Criteria:
* Idiopathic bronchiectasis with FEV1/FVC \< 70%
Exclusion Criteria:
* With Asthma
* α-1 antitrypsin deficiency
* Turculosis
* Lung cancer
* Sarcoidosis
* Idiopathic pulmonary fibrosis
* Primary pulmonary hypertension
* Uncontrolled sleep apnea
* Bronchiectasis accepted long-term low dose macrolides
* Pulmonary surgery within 6 months
* Lower respiratory tract infections require antibiotic treatment in 6 weeks
* Upper respiratory tract infection did not recover for at least 7 days
* With Glaucoma or severe prostate hyperplasia that can not use Indacaterol
* Patients allergic to experimental drugs
* Women pregnant, breast-feeding or who planned a pregnancy during the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04509661
Study Brief:
Protocol Section:
NCT04509661